Key takeaways
- This is for the practice owner or administrator who wants a defensible cost-per-patient number to take into a partner meeting — not a dashboard figure an agency produced, and not a patient-facing page about what treatment costs.
- A single blended acquisition cost for an orthopedic practice is close to meaningless. A workers’ compensation ankle, a commercial-plan reverse shoulder and a cash-pay injection do not belong in the same average, and neither do a referred patient and a self-referred one.
- Most practices cannot calculate this yet, and that is fine. The first thing worth paying for is the measurement — call tracking, form tracking and one question at intake. I will not invent a benchmark for you, because any industry figure I published would be a number I could not stand behind.
Who this page is for
I am Mandeep Singh. I have run Sprout Sage Solutions since 2020 from Chandigarh, India, working with US and international businesses. I lead every account personally, supported by a team of 17. Pricing is published below. No contract, cancel any month, keep everything I build.
Looking to hire rather than DIY? I run orthopedic marketing agency services on published pricing with no contract — cancel any month and keep everything I build. Book a free 30-minute call
This page is for a physician-owned orthopedic group that is being asked, internally or by a board, to justify a marketing line. It assumes you can get at your own numbers — new patient counts, payer mix, case mix — and that you would rather have an honest framework than a comforting figure.
It is not for a health system department, where the cost accounting sits somewhere else entirely. And it is not going to give you an industry average, because I do not have credible data on orthopedic acquisition cost across practices, and publishing a made-up range to look authoritative is exactly the thing that makes these numbers useless.
What patient acquisition cost actually means for a surgical practice
The textbook definition is total spend to acquire divided by patients acquired. For a surgical specialty, three things break that immediately.
First, a new patient is not the outcome. A consult that does not convert to a plan of care costs you a slot and produces very little. Second, the value of the patient varies enormously by payer and by whether the episode stays inside your walls. Third, a large share of your patients arrive through a channel you did not pay for this month and cannot switch on or off — the referral relationship — which makes any denominator that includes them dishonest and any denominator that excludes them incomplete.
So the useful question is not “what does a patient cost”. It is “what does an additional patient, in this service line, from this channel cost, and what is that patient worth to us after our contracted rates”. That is four numbers, and most practices have none of them.
Why a blended number is nearly useless here
Imagine you divide last quarter’s marketing spend by last quarter’s new patients. The result folds together a workers’ compensation shoulder referred by an occupational health clinic, a Medicare hip from a long-standing internist, a commercial-plan ACL from a parent who found you on a phone at eleven at night, and a cash-pay injection.
Those four cost different amounts to acquire, are worth wildly different amounts, and respond to completely different work. Averaging them produces a number that cannot inform a single decision. It will still look good on a slide, which is precisely the danger.
The minimum useful segmentation is by service line and by channel. If you can only afford one cut, cut by channel first — referred versus self-referred — because that is the split that tells you whether you are dependent on somebody else’s employment contract.
The denominator problem: attribution when channels overlap
Here is the case that breaks every attribution model in this specialty. A primary care physician hands a patient your surgeon’s name. The patient goes home, searches the name, lands on a hospital directory profile, then finds your procedure page, reads it for four minutes on a phone, and calls.
Was that a referral or a search patient? Your intake will record “referred by Dr X”. Your call tracking will record an organic search call. Both are true. Both are also incomplete, because the referral produced the intent and the page produced the booking.
I do not have a clever fix for this and I distrust anyone who claims one. What I do is measure both honestly and label the overlap rather than assigning it to whichever channel makes the report look better. In practice that means an intake question — “how did you hear about us” with a follow-up “and did you look us up before calling” — which is unglamorous and more accurate than any model.
Cost per new patient versus cost per surgical case
These are two different numbers and you need both.
Cost per new patient tells you whether your marketing is generating contacts. Cost per surgical case tells you whether those contacts are the right ones. A campaign that produces cheap consults for conditions you manage non-operatively can look excellent on the first number and terrible on the second.
The conversion rate between them is a clinical and operational fact about your practice, not a marketing lever, and it varies by subspecialty in ways that make cross-practice comparison worthless. Track it, but track it as context, not as a target — because the way to improve a consult-to-case ratio artificially is to see fewer appropriate patients, which is not something I will ever optimise for.
Payer mix and site of service change what a patient is worth
Two patients with the identical diagnosis and identical procedure can be worth substantially different amounts to you depending on the plan, the network status and the site of service. Everyone in your practice knows this. Almost no marketing report reflects it.
If you are going to spend money to generate demand, you should know which segments you actually want more of, and that is a decision about your payer mix and your capacity, not a marketing decision. I will build against whichever lines you name. What I will not do is decide for you which patients you want fewer of, and I will not write anything that screens patients by their coverage.
A group with an ownership stake in an ambulatory surgery centre, an imaging suite, a physical therapy line, DME or an orthobiologics programme keeps more of the episode. That does not change what acquisition costs; it changes what acquisition is worth, which changes which service lines justify the spend.
The practical consequence is that the lines worth marketing are often not the highest-volume ones. They are the ones where the episode stays with you. If you are going to build one acquisition cost model this year, build it on the line where you keep the most, and tell me which one that is before I decide what to build first.
Build the measurement before you build the model
Four things, none of them expensive, all of them prerequisites.
- Call tracking on the site and the profiles, so a call can be attributed to a source rather than guessed at. Numbers created under your ownership, so you keep them if you leave.
- Form tracking that records which page the request came from, because “the appointment page” and “the rotator cuff repair page” are different intents.
- One intake question, asked the same way every time by every scheduler. Consistency matters more than sophistication.
- A monthly reconciliation between what the tracking says and what the schedule says. Tracking alone overstates. Intake alone understates. The two together are close enough to act on.
This is the least interesting part of the engagement and the part that makes every later number defensible. It is included in Starter at $800 a month, which is deliberate — I would rather you have a real denominator in month two than a pretty report in month one.
A worked illustration, with your numbers to fill in
Here is the shape of the calculation. The figures below are placeholders to show the arithmetic, not benchmarks and not anything I have measured.
Say a practice spends the Core retainer of $1,500 a month plus some ad spend it controls. Say, purely as an illustration, that in a given month the tracking and intake together agree that a certain number of new patients came from search, and that a subset of those converted to cases in the line you were targeting. Divide the spend attributable to that line by that subset and you have a cost per case for that line, in that month.
Then do the only thing that makes it meaningful: compare it against what you know a case in that line is worth to you after contracted rates and cost to deliver, over a period long enough to matter. If the comparison is comfortable, you have your answer. If it is close, the variable to examine is almost never the ad bid — it is the intake, which is the next section.
I have deliberately not filled in the numbers. Any figure I supplied would be invented, and an invented benchmark is worse than no benchmark because people plan against it.
Front-desk leakage inflates your cost more than any bid
If a meaningful share of your inbound calls go unanswered, roll to voicemail, or get a three-week offer for an acute injury, your acquisition cost is inflated by exactly that share and no amount of bid management fixes it.
This is the single most common finding in a first-month audit and the cheapest to fix. Listen to the recordings from a Friday afternoon. Time how long the phone tree runs before a human. Find out how quickly an online request is answered. Ask whether anyone holds same-week slots for acute injuries.
I do not run your front desk and I will not pretend a marketing retainer solves an intake problem. I will show you the recordings and say plainly when the fix is a scheduling change rather than a marketing purchase — which sometimes means telling you not to increase your spend.
Fixed-cost and variable-cost marketing behave differently
Paid search is variable. You turn it up, cost goes up, contacts go up, and it stops the day you stop paying. Its acquisition cost is relatively easy to calculate and relatively honest.
Organic work — procedure pages, profiles, reviews, structure — is a fixed cost that compounds. In month two its acquisition cost looks appalling because the denominator is small. In month twelve the same spend is spread across a larger denominator and the same asset is still working. Comparing the two in the same month tells you almost nothing except which one you started more recently.
The practical rule: judge paid media monthly and judge organic work on a trailing basis over quarters. Any agency that presents them in the same column of the same table, in month three, is either confused or hoping you are.
What lifetime value means for an orthopedic patient, honestly
Lifetime value gets used to justify almost any acquisition cost, and in this specialty it deserves scepticism.
A knee patient may genuinely return for the other knee, for a shoulder in a decade, for therapy, for imaging, and may refer family members. That is real. It is also slow, uncertain and easy to inflate into a number that justifies whatever you already wanted to do. If you use lifetime value at all, use a conservative version of it and state the assumptions on the same slide. A partner who later finds the assumption was optimistic will not trust the next number you bring.
What I charge, and how it enters the calculation
Starter — $800 a month. Google Business Profile management for your locations. On-page fixes to your highest-intent pages: top procedures, surgeon bios, insurance and the appointment request. Review-request setup with visit-type filtering and response templates. Call and form tracking — the measurement described above. A monthly report and a call with me to read it.
Core — $1,500 a month. Everything in Starter, plus four published pieces a month aimed at procedure and second-opinion searches, surgeon-attributed and surgeon-reviewed. Location pages for each office. Practitioner profile buildout. Citation cleanup. Internal linking across the procedure clusters. Schema markup for the practice, the locations, the surgeons and the procedures.
Flat, so it is a known constant in your model rather than a percentage that grows with your spend. Not included: ad spend, Google Ads management, website rebuilds, photography and video, paid directory placements, and software you already run. The full breakdown including the internal hours nobody budgets for is on orthopedic practice marketing cost.
The claims I will not make, and the rules I work inside
- No surgical outcome claims of any kind, in any format.
- No patient-volume, case-volume or acquisition-cost promises. I will not tell you what your cost per patient will be, and a quantified volume promise made to a US medical practice is a claim somebody may eventually ask you to substantiate.
- No guaranteed rankings. Nobody controls Google’s results.
- No industry benchmark figures I cannot source. Where I use a number to show arithmetic, it is labelled as an illustration on the same line.
- No “best surgeon” superlatives. State medical boards treat unsubstantiated superlatives as false or misleading advertising, and the boards, not Google, are the ones who act.
- No patient imagery, stories or identifiable detail without a written HIPAA marketing authorisation. A consent for surgery is not a consent to publish.
- No testimonial describing a clinical result, and no incentivised or filtered reviews — the FTC’s endorsement rules apply alongside your board’s advertising rules.
- Nothing that pays for, rewards, or is contingent on a referral.
- Tracking scoped carefully. Call recordings and analytics are configured so that marketing tooling is not collecting more than it needs, and third-party advertising pixels do not go on pages where a visitor’s presence implies a condition. Where a vendor touches protected health information, that is a business associate question for your counsel, not something an agency should wave through.
I am not your attorney or your compliance officer. I write to these constraints by default and flag anything needing your counsel before it publishes rather than after.
What I can substantiate about my own track record
I have shipped 450+ websites since starting Sprout Sage Solutions in 2020. There are 17 Google reviews on the business profile.
None of the case studies on this site are orthopedic practices. The local SEO map pack rescue is closest in mechanics and the form rebuild teardown is relevant to intake. Those outcomes belong to those engagements in those markets and I am not presenting them as a forecast for yours. The full set is at the case studies hub.
What you keep if you leave
Everything, including the measurement. The tracking numbers are created under your ownership from day one, so your historical attribution data does not walk out of the door with me. The website and its pages, the Google Business Profiles in your name, the practitioner profiles, the review templates and workflow — all yours. No contracts, cancel any month.
Questions administrators ask about this number
What is a good patient acquisition cost for an orthopedic practice?
I do not know, and neither does anyone quoting you a figure without your payer mix and case mix in front of them. The only version of this question with an answer is comparative: is your cost per case in a named service line acceptable against what that case is worth to you, and is it moving in the right direction. Build that and ignore the industry average.
How long before the number is reliable?
The measurement is in place inside the first thirty days. The number becomes stable when you have enough volume in a segment for a month-to-month change to mean something, which for a subspecialty line in a single practice can take a while. Until then, read the direction, not the decimal.
Can you attribute a surgical case back to a specific page?
Partially and honestly. I can attribute the call or the form submission to the page and the source. Linking that to the case that happened six weeks later requires your schedule and your intake data, and it requires care about what patient information ends up in a marketing tool. I will show you where the chain of evidence ends rather than pretending it does not.
Our referrals are unpaid, so is our acquisition cost effectively zero?
No. Referral relationships have real costs — the liaison time, the reporting turnaround, the physician hours spent on relationships. They also carry a dependency risk that a cost figure does not capture, which is why I wrote separately about declining physician referrals in orthopedics.
Should we count the cost of the consult itself?
That is a decision for your finance side, and there is a reasonable argument either way. What matters more is being consistent about it, so that this quarter’s number can be compared with last quarter’s.
Does paid search always cost more per patient than organic?
Not necessarily, and the comparison is usually rigged by timing. Paid is expensive per patient and immediate. Organic is cheap per patient once the denominator has grown and produces nothing early. Judge them on different clocks.
Who owns the tracking data?
You do, from day one. I do not create tracking numbers or analytics properties under my own account, because that is a way of keeping clients who want to go.
Will you tell us to stop spending if the number does not work?
Yes, and it happens. A flat fee is what makes that advice free for me to give — an agency taking a percentage of your ad spend has a structural reason to recommend more of it.
Book a free 30-minute call
The call is free and there is no deck. I look at your profiles, your site and your search data live, and give you three specific things to fix that week whether or not you hire me. If your problem is measurement rather than marketing, I will tell you that on the call.
Book the free 30-minute call, or call me directly at +91 97297 12388.
For the wider picture, start with how I work with orthopedic practices, or read how to get more orthopedic patients. For the technical detail, see orthopedic surgeon SEO, and for the injury and athletic side, sports medicine marketing.
